Conestoga SMid Cap Composite Reports Q4 2025 Performance Drop

The Conestoga SMid Cap Composite experienced a decline in the fourth quarter of 2025, posting a total return of -2.71% net of fees. This performance fell short of the Russell 2500 Growth Index, which achieved a return of 0.33% during the same period. The volatility in relative performance marked a challenging quarter for the composite, primarily driven by negative stock selection in key sectors.

Stock selection in the Industrials and Real Estate sectors significantly contributed to the composite’s underperformance. Additionally, the composite’s underweight position in the highly volatile biotechnology industry further detracted from overall returns. These factors created a complex investment landscape, impacting the strategy’s effectiveness.

Performance Analysis for Q4 2025

The Conestoga SMid Cap Composite specifically faced challenges in sectors that were expected to perform well. Stock selection within the Industrials sector proved detrimental, as many companies underperformed relative to their peers. Similarly, the Real Estate sector also saw negative impacts, resulting in lower overall returns for the composite.

Despite these challenges, the decision to maintain an underweight position in biotechnology, while initially strategic, ultimately resulted in missed opportunities as that sector exhibited higher volatility and potential for growth during the quarter. The performance of the composite highlights the importance of sector allocation and stock selection in achieving investment objectives.

Throughout the quarter, market conditions fluctuated, with various factors influencing investor sentiment and stock performance. As the composite navigated these complexities, the overall strategy demonstrated the importance of ongoing assessment and adjustment in response to shifting market dynamics.

Looking ahead, the investment team remains committed to refining their approach, focusing on sectors that align with their long-term growth outlook. The analysis of Q4 2025’s performance will inform future strategies, as the team aims to enhance returns while managing risks effectively in an ever-evolving market landscape.

In summary, the Conestoga SMid Cap Composite’s -2.71% return in Q4 2025 underscores the challenges faced during a volatile quarter, largely driven by stock selection in key sectors and an underweight in biotechnology. The insights gained from this performance will be crucial as the team prepares for future market conditions.